133.14
Align Technology Inc stock is traded at $133.14, with a volume of 873.26K.
It is down -1.85% in the last 24 hours and up +5.51% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$135.65
Open:
$134.94
24h Volume:
873.26K
Relative Volume:
0.54
Market Cap:
$9.65B
Revenue:
$3.98B
Net Income/Loss:
$409.56M
P/E Ratio:
24.25
EPS:
5.49
Net Cash Flow:
$630.74M
1W Performance:
-2.26%
1M Performance:
+5.51%
6M Performance:
-26.48%
1Y Performance:
-38.30%
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology Inc
|
133.14 | 9.83B | 3.98B | 409.56M | 630.74M | 5.49 |
|
ISRG
Intuitive Surgical Inc
|
545.39 | 195.42B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
184.21 | 53.61B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.82 | 37.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
256.57 | 37.83B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
283.49 | 20.66B | 2.96B | 487.70M | 344.00M | 6.6758 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Real time social sentiment graph for Align Technology Inc. - newser.com
Will Align Technology Inc. stock deliver strong dividend growthEarnings Beat & Weekly Watchlist of Top Performers - newser.com
Align Technology: Hold Rating Amid Market Challenges and Uncertain Growth Prospects - TipRanks
Is Align Technology Inc. stock overvalued by current metricsEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Align Technology Inc. recovery potential after sell offMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com
How to escape a deep drawdown in Align Technology Inc.2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Visual analytics tools that track Align Technology Inc. performanceJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com
How Align Technology Inc. stock reacts to bond yieldsEntry Point & Reliable Volume Spike Alerts - Fundação Cultural do Pará
Align Technology (ALGN) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Align Technology’s Clinical Study: A Game Changer in Orthodontics? - TipRanks
Is Align Technology Inc. stock trading near support levels2025 Volatility Report & Expert Curated Trade Setups - newser.com
Align Technology Experiences Revision in Its Stock Evaluation Amid Market Fluctuations - Markets Mojo
Dental Treatment Consumables Market Size Growth of $50.60 - openPR.com
Piper Sandler maintains Overweight rating on Align Technology stock - Investing.com
Align Technology's Valuation Adjusted Amidst Strong Management Efficiency and Premium Trading Ratios - Markets Mojo
LuxCreo & Angelalign Technology to co-develop next-gen 3D printing materials for clear aligner therapy - TCT Magazine
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):